SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Zealand Pharma Announces Further Positive Results Presented by Sanofi (France) From the GetGoal Phase III Program for Lixisenatide (Lyxumia(R)1)) in Type 2 Diabetes